Azenta (AZTA) Share-based Compensation (2010 - 2026)
Azenta's (AZTA) quarterly Share-based Compensation came in at $10.4 million in Q1 2026, up 29.75% year-on-year from $8.0 million in Q1 2025, and down 75.54% on a QoQ basis from $42.6 million in Q4 2025.
Azenta (AZTA) Share-based Compensation (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 17 years of Share-based Compensation data on file, last reported at $10.4 million in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 29.75% year-over-year to $10.4 million in Q1 2026; TTM through Mar 2026 was $25.8 million, a 512.01% increase from a year earlier, with the FY2025 full-year figure at $42.6 million, changed N/A from the prior year.
- Share-based Compensation for Q1 2026 stood at $10.4 million, down from $42.6 million in the prior quarter.
- Over the last five years, Share-based Compensation for AZTA reached as high as $42.6 million in Q4 2025 and fell as low as -$12.6 million in Q3 2024.
- Historically, Share-based Compensation has averaged $5.7 million across 5 years, with a median of $3.7 million in 2024.
- Across the five-year window, Share-based Compensation plunged 147.34% in 2024 and jumped 733.33% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $2.1 million in 2022, then jumped by 52.11% to $3.2 million in 2023, then soared by 59.65% to $5.1 million in 2024, then soared by 733.33% to $42.6 million in 2025, then slumped by 75.54% to $10.4 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $10.4 million in Q1 2026, $42.6 million in Q4 2025, and $20.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Azenta | 1.30 Bn | 1.07 Bn | 125.74 Mn | 10.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.42 Mn |
| Mar 31, 2026 | 10.42 Mn |
| Dec 31, 2025 | 42.60 Mn |
| Dec 31, 2025 | 42.60 Mn |
| Sep 30, 2025 | 20.80 Mn |
| Sep 30, 2025 | 20.80 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 8.03 Mn |
| Mar 31, 2025 | 8.03 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | -12.62 Mn |
| Sep 30, 2024 | -12.62 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 5.41 Mn |
| Mar 31, 2024 | 5.41 Mn |
| Dec 31, 2023 | 3.20 Mn |
| Dec 31, 2023 | 3.20 Mn |